Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers

NCT00632008 ↗

Phase 3 Completed 122 enrolled Biotec Pharmacon ASA

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine whether the application of soluble beta-glucan (SBG) onto diabetic foot ulcers improves the healing of the ulcers.

Timeline

Start: 2007-03
Primary completion: 2009-08
Completion: 2009-10

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Soluble beta-glucan	Unknown	—	Topical

Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers

Summary

Timeline

Drugs

Indications